A 544-patient TECAB programme series
Balkhy was first author of the retrospective 2013–2020 series: 56% underwent multivessel TECAB, one case converted to sternotomy and reported mortality was 0.9%. Early graft patency was 97% in the assessed hybrid-revascularization patients.
How to interpret this: Single-centre selected cohort, mean STS risk 1.7%; patency was assessed in a subgroup. These are historical programme results, not a guarantee or a current personal success rate.
